Ekso Intangibles To Total Assets from 2010 to 2024

EKSO Stock  USD 1.30  0.06  4.41%   
Ekso Bionics Intangibles To Total Assets yearly trend continues to be very stable with very little volatility. Intangibles To Total Assets are likely to grow to 0.19 this year. Intangibles To Total Assets is the ratio of a company's intangible assets (like goodwill and patents) to its total assets. View All Fundamentals
 
Intangibles To Total Assets  
First Reported
2010-12-31
Previous Quarter
0.1840722
Current Value
0.19
Quarterly Volatility
0.06062067
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ekso Bionics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ekso main balance sheet or income statement drivers, such as Interest Expense of 271.3 K, Selling General Administrative of 8.7 M or Other Operating Expenses of 28.5 M, as well as many exotic indicators such as Price To Sales Ratio of 1.8, Dividend Yield of 0.11 or PTB Ratio of 2.61. Ekso financial statements analysis is a perfect complement when working with Ekso Bionics Valuation or Volatility modules.
  
This module can also supplement Ekso Bionics' financial leverage analysis and stock options assessment as well as various Ekso Bionics Technical models . Check out the analysis of Ekso Bionics Correlation against competitors.

Latest Ekso Bionics' Intangibles To Total Assets Growth Pattern

Below is the plot of the Intangibles To Total Assets of Ekso Bionics Holdings over the last few years. It is the ratio of a company's intangible assets (like goodwill and patents) to its total assets. Ekso Bionics' Intangibles To Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ekso Bionics' overall financial position and show how it may be relating to other accounts over time.
Intangibles To Total Assets10 Years Trend
Slightly volatile
   Intangibles To Total Assets   
       Timeline  

Ekso Intangibles To Total Assets Regression Statistics

Arithmetic Mean0.08
Geometric Mean0.06
Coefficient Of Variation75.42
Mean Deviation0.05
Median0.06
Standard Deviation0.06
Sample Variance0
Range0.1814
R-Value0.68
Mean Square Error0
R-Squared0.46
Significance0.01
Slope0.01
Total Sum of Squares0.05

Ekso Intangibles To Total Assets History

2024 0.19
2023 0.18
2020 0.14
2019 0.008624
2018 0.0107
2017 0.0179
2016 0.0497

About Ekso Bionics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Ekso Bionics income statement, its balance sheet, and the statement of cash flows. Ekso Bionics investors use historical funamental indicators, such as Ekso Bionics's Intangibles To Total Assets, to determine how well the company is positioned to perform in the future. Although Ekso Bionics investors may use each financial statement separately, they are all related. The changes in Ekso Bionics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ekso Bionics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ekso Bionics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ekso Bionics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Intangibles To Total Assets 0.18  0.19 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Check out the analysis of Ekso Bionics Correlation against competitors.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Ekso Stock analysis

When running Ekso Bionics' price analysis, check to measure Ekso Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ekso Bionics is operating at the current time. Most of Ekso Bionics' value examination focuses on studying past and present price action to predict the probability of Ekso Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ekso Bionics' price. Additionally, you may evaluate how the addition of Ekso Bionics to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Is Ekso Bionics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.97)
Revenue Per Share
1.202
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.26)
Return On Equity
(0.81)
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.